FDA Approval Summary: Nivolumab in Combination with Ipilimumab for the Treatment of Unresectable Malignant Pleural Mesothelioma.Erica C. Nakajima,Paz J. Vellanki,Erin Larkins,Somak Chatterjee,Pallavi S. Mishra-Kalyani,Youwei Bi,Hisham Qosa,Jiang Liu,Hong Zhao,Missiratch Biable,Lauren Tesh Hotaki,Yuan-Li Shen,Richard Pazdur,Julia A. Beaver,Harpreet Singh,Martha DonoghueClinical Cancer Research(2022)引用 21|浏览27暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要